These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19032081)

  • 1. In silico functional profiling of small molecules and its applications.
    Sato T; Matsuo Y; Honma T; Yokoyama S
    J Med Chem; 2008 Dec; 51(24):7705-16. PubMed ID: 19032081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CLEVER: pipeline for designing in silico chemical libraries.
    Song CM; Bernardo PH; Chai CL; Tong JC
    J Mol Graph Model; 2009 Jan; 27(5):578-83. PubMed ID: 18986817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach.
    Ebbels TM; Keun HC; Beckonert OP; Bollard ME; Lindon JC; Holmes E; Nicholson JK
    J Proteome Res; 2007 Nov; 6(11):4407-22. PubMed ID: 17915905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-based approach to in silico pharmacology: nuclear receptor profiling.
    Mestres J; Martín-Couce L; Gregori-Puigjané E; Cases M; Boyer S
    J Chem Inf Model; 2006; 46(6):2725-36. PubMed ID: 17125212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrated in silico analysis of drug-binding to human serum albumin.
    Estrada E; Uriarte E; Molina E; Simón-Manso Y; Milne GW
    J Chem Inf Model; 2006; 46(6):2709-24. PubMed ID: 17125211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From virtuality to reality - Virtual screening in lead discovery and lead optimization: a medicinal chemistry perspective.
    Rester U
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):559-68. PubMed ID: 18600572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
    Bender A; Scheiber J; Glick M; Davies JW; Azzaoui K; Hamon J; Urban L; Whitebread S; Jenkins JL
    ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling in drug discovery and development.
    Stratowa C; Wilgenbus KK
    Curr Opin Mol Ther; 1999 Dec; 1(6):671-9. PubMed ID: 19629863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond profiling: using ADMET models to guide decisions.
    Segall M; Champness E; Obrezanova O; Leeding C
    Chem Biodivers; 2009 Nov; 6(11):2144-51. PubMed ID: 19937845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic algorithm-optimized QSPR models for bioavailability, protein binding, and urinary excretion.
    Wang J; Krudy G; Xie XQ; Wu C; Holland G
    J Chem Inf Model; 2006; 46(6):2674-83. PubMed ID: 17125207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of molecular topology to the prediction of the antimalarial activity of a group of uracil-based acyclic and deoxyuridine compounds.
    García-Domenech R; López-Peña W; Sanchez-Perdomo Y; Sanders JR; Sierra-Araujo MM; Zapata C; Gálvez J
    Int J Pharm; 2008 Nov; 363(1-2):78-84. PubMed ID: 18675892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of pH-dependent aqueous solubility of druglike molecules.
    Hansen NT; Kouskoumvekaki I; Jørgensen FS; Brunak S; Jónsdóttir SO
    J Chem Inf Model; 2006; 46(6):2601-9. PubMed ID: 17125200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of self-organizing neural networks in virtual screening and diversity selection.
    Selzer P; Ertl P
    J Chem Inf Model; 2006; 46(6):2319-23. PubMed ID: 17125175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrafast shape recognition: evaluating a new ligand-based virtual screening technology.
    Ballester PJ; Finn PW; Richards WG
    J Mol Graph Model; 2009 Apr; 27(7):836-45. PubMed ID: 19188082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NIPALSTREE: a new hierarchical clustering approach for large compound libraries and its application to virtual screening.
    Böcker A; Schneider G; Teckentrup A
    J Chem Inf Model; 2006; 46(6):2220-9. PubMed ID: 17125166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico classification of adenosine receptor antagonists using Laplacian-modified naïve Bayesian, support vector machine, and recursive partitioning.
    Lee JH; Lee S; Choi S
    J Mol Graph Model; 2010 Jun; 28(8):883-90. PubMed ID: 20447849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining cluster analysis, feature selection and multiple support vector machine models for the identification of human ether-a-go-go related gene channel blocking compounds.
    Nisius B; Göller AH; Bajorath J
    Chem Biol Drug Des; 2009 Jan; 73(1):17-25. PubMed ID: 19152631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New QSPR study for the prediction of aqueous solubility of drug-like compounds.
    Duchowicz PR; Talevi A; Bruno-Blanch LE; Castro EA
    Bioorg Med Chem; 2008 Sep; 16(17):7944-55. PubMed ID: 18701302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecule evoluator. An interactive evolutionary algorithm for the design of drug-like molecules.
    Lameijer EW; Kok JN; Bäck T; Ijzerman AP
    J Chem Inf Model; 2006; 46(2):545-52. PubMed ID: 16562982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cluster-based strategy for assessing the overlap between large chemical libraries and its application to a recent acquisition.
    Engels MF; Gibbs AC; Jaeger EP; Verbinnen D; Lobanov VS; Agrafiotis DK
    J Chem Inf Model; 2006; 46(6):2651-60. PubMed ID: 17125205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.